MELOSO BAR - AN OVERVIEW

In addition, it addresses the FDA’s communications With all the applicant, the retention of records that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of the SE report to a whole new applicant and electronic submission in the SE report